Carlsmed (CARL) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Carlsmed (CARL) is Neutral.

The composite score behind that read is -0.18, weighing +0.11 of bullish evidence against -0.27 bearish.

Carlsmed last closed at $14.38, -1.78% on the session.

Against the IVW growth benchmark the position is -1.62% over the forecast window.

The read is built from 12 underlying insights — 3 bullish and 9 bearish.

Agreement across those insights is 75%.

18 graded predictions for CARL so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Carlsmed in the 21st percentile on return on equity, where 100 is best.

Carlsmed is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $399.72M.

StockMap tracks Carlsmed as the 79th largest of the 138 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 72 Neutral, 60 Moderate Underperform, 5 Strong Underperform and 1 Moderate Outperform.

On that composite Carlsmed ranks 62nd of 138 in the group, against a group median of -0.18.